Studies have demonstrated that curcumin enhances the activity of PD-1/PD-L1 antibodies in murine colon cancer (MC38 and CT26) and liver cancer (Hep3B) cells by effectively preventing immune evasion [370, 371]. This evidence concerns the gene CD274 and liver cancer.